Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Amarin Corporation PLC (AMRN)

« Back to company index

AMRN Chatter Timeline

Stock Ticker for AMRN

Most Active Tweeters for AMRN

UserTweets
@bonjour247 11
@prosperousguy 8
@UNCLEJAYROCKS 6
@askwarrenbuffet 6
@ra_fun 5

Recent Tweets for AMRN

myLSshops @myLSshops
Long $AMRN: Players betting on merger have mostly left. Players betting on EU expansion in sales are remaining and… https://t.co/pRpCKaVvU4
4:04am
TradeWithAlerts @TradeWithAlerts
Large Print $AMRN Size: 185000 Price: 5.035 Time: 1014 Amount: $931,475.00
April 19th 2021, 2:04pm
Briefingcom @Briefingcom
$AMRN: Amarin Vascepa reported to impact vulnerable coronary plaque features in new analyses of Evaporate study... https://t.co/yKLa3qjWrh
April 19th 2021, 11:04am
kevinjaybe @kevinjaybe
$AMRN Vascepa® (Icosapent Ethyl) Reported To Impact Vulnerable Coronary Plaque Features In New Analyses Of Evaporat… https://t.co/pliUJa8Asz
April 19th 2021, 5:04am
botpicks @botpicks
Should I Go Long or Short $AMRN ?
April 19th 2021, 1:04am
TradingAloha @TradingAloha
Doubled position in $AMRN this week in long-term accounts. Love the CEO finally getting out of the way. They hold h… https://t.co/jlxNfof3HY
April 19th 2021, 12:04am
askwarrenbuffet @askwarrenbuffet
$AMRN To Reveal New Significant Investment In Company From Leading Chicago Based Institutional Fund… https://t.co/cuj8U5DjEV
April 18th 2021, 11:04pm
sbwcws @sbwcws
Amarin presents new analyses of EVAPORATE study $AMRN
April 18th 2021, 8:04pm
PorqueNoTrade @PorqueNoTrade
$AMRN VASCEPA Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study #Stocks… https://t.co/g2axSJVAPE
April 18th 2021, 8:04am
BrickStreetWolf @BrickStreetWolf
On March 30 $AMRN got approval for Vazkepa April 17 they reported it works ?
April 18th 2021, 3:04am
askwarrenbuffet @askwarrenbuffet
$AMRN Share Price To Rise, Announcement Of Joint Venture With Top US Ivy League University https://t.co/Mv3xmUJu9A… https://t.co/FYnw8rdSGa
April 17th 2021, 10:04pm
IncredibleTrade @IncredibleTrade
$AMRN VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORAT… https://t.co/z8939HzuJm
April 17th 2021, 8:04pm
chiragontwtr @chiragontwtr
$amrn EU indication is broader than US & target pt. population is ~105% of that in USA. $1.1B EU sales in 2029. Sh… https://t.co/nqcmR6RS1s
April 17th 2021, 6:04pm
KevinRafalski @KevinRafalski
RT @ra_fun: Rate the overall performance of $AMRN management to date ????
April 17th 2021, 4:04pm
ra_fun @ra_fun
Rate the overall performance of $AMRN management to date ????
April 17th 2021, 3:04pm
PaulAzzaro @PaulAzzaro
You’re welcome [email protected]? $AMRN https://t.co/ZrD7HIRESG
April 17th 2021, 3:04pm
otcdynamics @otcdynamics
$AMRN VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORAT… https://t.co/7I9Q2owGfD
April 17th 2021, 2:04pm
nubostongeorge @nubostongeorge
$AMRN - VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of https://t.co/WeMVC6u9Y8
April 17th 2021, 1:04pm
FlashAlert_me @FlashAlert_me
$AMRN [15s. delayed]: Issued Press Release on April 17, 09:50:00: VASCEPA® (Icosapent Ethyl) Reported to Impact Vul… https://t.co/dZYDERwUpS
April 17th 2021, 1:04pm
stock_titan @stock_titan
$AMRN VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORAT… https://t.co/2lcettFQCv
April 17th 2021, 1:04pm
TOWiU2 @TOWiU2
$AMRN - With Their European Approval In Hand, Amarin Signals A Strategic Shift With A New CEO.… https://t.co/b4x1iLCFED
April 17th 2021, 9:04am
TOWiU2 @TOWiU2
Amarin launches Vascepa in all-important Europe as it slowly bleeds share to U.S. generic https://t.co/6IREdm6Y2v $amrn
April 17th 2021, 9:04am
TOWiU2 @TOWiU2
With crucial EU launch rolling, Amarin's Thero hands CEO baton to new European commercial chief $amrn https://t.co/3ft1ne7G5O
April 17th 2021, 9:04am
ra_fun @ra_fun
@Amarincorp @DLBHATTMD Do these peers know that your R&D website has not been updated in over 2 years? $AMRN… https://t.co/qhbdOvCF1v
April 16th 2021, 8:04pm
UKiwiS @UKiwiS
$AMRN green? Wtf?
April 16th 2021, 6:04pm
TheStreet @TheStreet
@BruceKamich reviews the charts and indicators Amarin Corp. ( $AMRN ). (via @realmoney) https://t.co/tf0yGljoHp
April 15th 2021, 7:04pm
ra_fun @ra_fun
@Amarincorp Seriously? $AMRN
April 15th 2021, 7:04pm
Bu_LLss @Bu_LLss
$AMRN For Long time investors, time to Buy this area
April 15th 2021, 1:04pm
josiahmp @josiahmp
Wait, JT is finally leaving $AMRN and the stock drops on that news? We are living in a bizarro world...
April 15th 2021, 12:04pm
mediasentiment @mediasentiment
$AMRN new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 132
April 15th 2021, 10:04am
UNCLEJAYROCKS @UNCLEJAYROCKS
$AMRN CRAPPED ON BY CRAMER BUT HE ONCE LOVED THEM LOL UNREAL
April 14th 2021, 10:04pm
joaquinkam @joaquinkam
@chiragontwtr Can you estimate $AMRN 2022 revenue?, according to my estimation now is highly undervalued.
April 14th 2021, 9:04pm
chiragontwtr @chiragontwtr
Huge if true.. $AMRN https://t.co/JTAIqVYeuB
April 14th 2021, 4:04pm
MarcJacksonLA @MarcJacksonLA
$AMRN Amarin Become’s Oversold | NASDAQ https://t.co/sYu1wMOFe3
April 14th 2021, 3:04pm
MarcJacksonLA @MarcJacksonLA
$AMRN Amarin: Could the New CEO Help Vazkepa’s European Push? https://t.co/3oJeHdzwbw
April 14th 2021, 3:04pm
noodle_to @noodle_to
$AMRN lets go AMRN, I see you!
April 14th 2021, 1:04pm
WALLSTREETODDS_ @WALLSTREETODDS_
$AMRN Out of the 5 other times AMRN was down 13.0% during a trading day, 60% of the time it traded lower by the ne… https://t.co/6tYdMwTGzx
April 14th 2021, 2:04am
joaquinkam @joaquinkam
@chiragontwtr They had a potential market that in other hand would take off at 5x speed, = $AMRN EU China Canada ..
April 14th 2021, 2:04am
BiopharmIQ @BiopharmIQ
$AMRN -13% on 4/13/21 on 5x avg. volume apparently due to analyst M&A chatter as a result of CEO's announced retire… https://t.co/BMtdLLBBwp
April 14th 2021, 1:04am
joaquinkam @joaquinkam
$AMRN Ceo resignation is a step forward to be acquired soon I remember recent examples like $PTLA (180% premium)… https://t.co/zfLgOa90jD
April 13th 2021, 10:04pm
BiopharmIQ @BiopharmIQ
$AMRN -12% CEO retires View analysis conducted by an experienced biotech patent attorney here: https://t.co/POl3PewCK5
April 13th 2021, 10:04pm
prosperousguy @prosperousguy
@bonjour247 I got hosed on $AMRN calls as well the past few weeks, Very disappointed in SP action, just horrific, t… https://t.co/PuIoYYVi6G
April 13th 2021, 10:04pm
chucknfones @chucknfones
Haha $AMRN was down on the news of the CEO leaving but he’s ruined that company so I’m thinking it’s a buy now. Wha… https://t.co/CgKD2XKrcF
April 13th 2021, 10:04pm
prosperousguy @prosperousguy
@bonjour247 No buy and hold on $AMRN for 2022, I make better % from shorter term plays and options.
April 13th 2021, 9:04pm
prosperousguy @prosperousguy
@bonjour247 That's my point, $AMRN $5.10 IS too cheap, that's why they are Vulnerable. The sharks circle when ther… https://t.co/PJW3X08LTM
April 13th 2021, 9:04pm
SeekingAlpha @SeekingAlpha
$AMRN - With Their European Approval In Hand, Amarin Signals A Strategic Shift With A New CEO.… https://t.co/KcS57L3xkQ
April 13th 2021, 9:04pm
BiotechBiggums @BiotechBiggums
@LTbioinvestor $AMRN says otherwise
April 13th 2021, 9:04pm
prosperousguy @prosperousguy
@bonjour247 IMO $AMRN $5.10 is a sitting duck for a BO right NOW. Like a Turtle on its back; Vulnerable At this… https://t.co/PhNfesMLrg
April 13th 2021, 9:04pm
nubostongeorge @nubostongeorge
$AMRN - Amarin: Could the New CEO Help Vazkepa’s European Push? https://t.co/RvZCLQGMpq
April 13th 2021, 8:04pm
HitTheBidRadio @HitTheBidRadio
$AMRN It’s the 27th Anniversary of this stock sucking. After selling calls against it my cost average is negative… https://t.co/yz3xpbajMv
April 13th 2021, 8:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.